Biogen UK Ltd

About Biogen (UK) Ltd

Biogen (UK) Ltd is a leading biotechnology company dedicated to discovering, developing, and delivering innovative therapies for neurological diseases. Founded in 1978, Biogen has been at the forefront of scientific advancements, focusing on areas such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease.

With a commitment to improving patient outcomes, Biogen invests heavily in research and development, collaborating with academic institutions and healthcare professionals worldwide. The company’s mission is to provide meaningful solutions that enhance the quality of life for individuals affected by debilitating conditions.

Biogen (UK) Ltd operates with a strong emphasis on sustainability and corporate responsibility, ensuring that its operations positively impact the communities it serves. The company adheres to the highest ethical standards in its clinical trials and product development processes.

In addition to its innovative therapies, Biogen offers comprehensive support programs for patients and healthcare providers, ensuring access to vital treatments and resources. The company’s dedication to education and awareness is evident through various initiatives aimed at informing the public about neurological disorders.

As a global leader in biotechnology, Biogen continues to expand its portfolio, exploring new therapeutic areas and technologies. The company’s vision is to transform the treatment landscape for neurological diseases, ultimately striving for a world where every individual can lead a fulfilling life.

• Founded: 1978
• Core Focus: Neurological diseases
• Commitment: Research and development
• Ethics: High ethical standards in clinical trials